Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a Prostate cancer tag and related topics (MedlinePlus Genetics); the revision is updated to v3.5.5.SummaryDifference0.1%

- Check8 days agoChange DetectedProstate cancer labeling and the related topics reference (MedlinePlus Genetics) were removed from the page. This changes how the study's disease context and connections to related resources are presented.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page now lists Prostate cancer as a related topic and adds MedlinePlus Genetics under related topics, expanding cross-reference information for readers.SummaryDifference0.1%

- Check22 days agoChange DetectedA new Lancet Oncology TALAPRO-1 citation was added to the Publications section. The earlier Lancet Oncology entry, including its erratum, was removed.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI rather than any study information.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded a new Lancet Oncology TALAPRO-1 publication citation (de Bono et al., 2021) with an erratum in 2022 and updated the revision to v3.5.2. Removed the older TALAPRO-1 citation with revision v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.